Daily Stock Analysis, EIRL, CELLADON CORPORATION - COMMON STOCK, priceseries

CELLADON CORPORATION - COMMON STOCK. Daily Stock Analysis
Stock Information
Open
39.18
Close
39.28
High
39.51
Low
39.15
Previous Close
39.37
Daily Price Gain
-0.09
YTD High
43.27
YTD High Date
Apr 22, 2019
YTD Low
36.57
YTD Low Date
Jan 3, 2019
YTD Price Change
2.68
YTD Gain
7.31%
52 Week High
46.28
52 Week High Date
Aug 30, 2018
52 Week Low
35.59
52 Week Low Date
Dec 24, 2018
52 Week Price Change
-6.40
52 Week Gain
-14.01%
Company Information
Stock Symbol
EIRL
Exchange
NasdaqGM
Company URL
http://www.eigerbio.com
Company Phone
650-279-9845
CEO
David A. Cory
Headquarters
California
Business Address
350 CAMBRIDGE AVE, SUITE 350, PALO ALTO, CA 94306
Sector
-
Industry Category
-
Industry Group
-
CIK
0001305253
About

Eiger BioPharmaceuticals, Inc. is a clinical-stage company, which engages in the research, development, and commercialization of biopharmaceutical products. It focuses on product candidates for the treatment of orphan diseases such as Sarasar, Pegylated Interferon Lambda, Exendin 9-39, and Ubenimex. The company was founded by David A. Cory on November 6, 2008 and is headquartered in Palo Alto, CA.

Description

Eiger BioPharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on providing various products for the treatment of orphan diseases in the United States. It portfolio of products include Sarasar, an indication for the hepatitis delta virus infection; Exendin, which is used for the treatment of hypoglycemia associated with bariatric surgery; and Bestatin that is used for the treatment of pulmonary arterial hypertension and lymphedema, which are under Phase II clinical trials. The company was founded in 2008 and is headquartered in Palo Alto, California.